<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>77(6)</volume><submitter>Andre C</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Increasing evidence suggests that sleep-disordered breathing (SDB) increases the risk of developing Alzheimer clinical syndrome. However, the brain mechanisms underlying the link between SDB and Alzheimer disease are still unclear.&lt;h4>Objective&lt;/h4>To determine which brain changes are associated with the presence of SDB in older individuals who are cognitively unimpaired, including changes in amyloid deposition, gray matter volume, perfusion, and glucose metabolism.&lt;h4>Design, setting, and participants&lt;/h4>This cross-sectional study was conducted using data from the Age-Well randomized clinical trial of the Medit-Ageing European project, acquired between 2016 and 2018 at Cyceron Center in Caen, France. Community-dwelling older adults were assessed for eligibility and wer</pubmed_abstract><journal>JAMA neurology</journal><pagination>716-724</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7091393</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial.</pubmed_title><pmcid>PMC7091393</pmcid><pubmed_authors>Medit-Ageing Research Group</pubmed_authors><pubmed_authors>Ourry V</pubmed_authors><pubmed_authors>Marchant NL</pubmed_authors><pubmed_authors>Lutz A</pubmed_authors><pubmed_authors>Rehel S</pubmed_authors><pubmed_authors>Bejanin A</pubmed_authors><pubmed_authors>de la Sayette V</pubmed_authors><pubmed_authors>Mezenge F</pubmed_authors><pubmed_authors>Abbas A</pubmed_authors><pubmed_authors>de Flores R</pubmed_authors><pubmed_authors>Chetelat G</pubmed_authors><pubmed_authors>Landeau B</pubmed_authors><pubmed_authors>Collette F</pubmed_authors><pubmed_authors>Kuhn E</pubmed_authors><pubmed_authors>Sherif S</pubmed_authors><pubmed_authors>Bertran F</pubmed_authors><pubmed_authors>Rauchs G</pubmed_authors><pubmed_authors>Le Du G</pubmed_authors><pubmed_authors>Tomadesso C</pubmed_authors><pubmed_authors>Arenaza-Urquijo EM</pubmed_authors><pubmed_authors>Touron E</pubmed_authors><pubmed_authors>Andre C</pubmed_authors><pubmed_authors>Delcroix N</pubmed_authors><pubmed_authors>Moulinet I</pubmed_authors><pubmed_authors>Vivien D</pubmed_authors><pubmed_authors>Manrique A</pubmed_authors><pubmed_authors>Klimecki OM</pubmed_authors><pubmed_authors>Poisnel G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial.</name><description>&lt;h4>Importance&lt;/h4>Increasing evidence suggests that sleep-disordered breathing (SDB) increases the risk of developing Alzheimer clinical syndrome. However, the brain mechanisms underlying the link between SDB and Alzheimer disease are still unclear.&lt;h4>Objective&lt;/h4>To determine which brain changes are associated with the presence of SDB in older individuals who are cognitively unimpaired, including changes in amyloid deposition, gray matter volume, perfusion, and glucose metabolism.&lt;h4>Design, setting, and participants&lt;/h4>This cross-sectional study was conducted using data from the Age-Well randomized clinical trial of the Medit-Ageing European project, acquired between 2016 and 2018 at Cyceron Center in Caen, France. Community-dwelling older adults were assessed for eligibility and wer</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2026-05-01T17:25:48.624Z</modification><creation>2025-02-19T03:41:13.262Z</creation></dates><accession>S-EPMC7091393</accession><cross_references><pubmed>32202593</pubmed><doi>10.1001/jamaneurol.2020.0311</doi></cross_references></HashMap>